Sale!

 Ibrutix

$500.00 $420.00

Ibrutix (Ibrutinib) is a kinase inhibitor indicated for the treatment of patients with:Mantle cell lymphoma (MCL), Chronic lymphocytic leukemia (CLL) who have received at least one prior therapy, Chronic lymphocytic leukemia with 17p deletion, Waldenström’s macroglobulinemia (WM) who have received at least one prior therapy.

[pl_row]
[pl_col col=12]
[pl_text]

Ibrutix (Ibrutinib)

 

Product Description: Ibrutix (Ibrutinib) is a kinase inhibitor indicated for the treatment of patients with: Mantle Cell Lymphoma (MCL) who have received at least one prior therapy, Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) with 17p deletion, Waldenström’s Macroglobulinemia (WM), Marginal Zone Lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy. Ibrutix is available in capsule form for oral administration. Capsules should be taken orally with a glass of water. Do not open, break, or chew the capsules.

Product Features:

Product Name : Ibrutix
Generic Name : Ibrutinib INN
Formulation : Capsule
Available Pack Size : 120’s in a bottle
Available Strength : 140 mg
Registrations : Bangladesh
Website www.ibrutix.com

[/pl_text]
[/pl_col]
[/pl_row]

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

  • Sale! IbrucentIbrucent

    Ibrucent

    Anti cancer $500.00 $400.00
    Rated 0 out of 5